CN105814195A - 层粘连蛋白应用于角膜内皮细胞培养 - Google Patents

层粘连蛋白应用于角膜内皮细胞培养 Download PDF

Info

Publication number
CN105814195A
CN105814195A CN201480065134.XA CN201480065134A CN105814195A CN 105814195 A CN105814195 A CN 105814195A CN 201480065134 A CN201480065134 A CN 201480065134A CN 105814195 A CN105814195 A CN 105814195A
Authority
CN
China
Prior art keywords
laminin
chain
corneal endothelial
endothelial cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480065134.XA
Other languages
English (en)
Chinese (zh)
Inventor
小泉范子
奥村直毅
木下茂
F·E·克鲁斯
U·施罗泽尔-施瑞哈特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Doshisha Co Ltd
Kyoto Prefectural PUC
Original Assignee
Senju Pharmaceutical Co Ltd
Doshisha Co Ltd
Kyoto Prefectural PUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Doshisha Co Ltd, Kyoto Prefectural PUC filed Critical Senju Pharmaceutical Co Ltd
Publication of CN105814195A publication Critical patent/CN105814195A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201480065134.XA 2013-11-27 2014-11-26 层粘连蛋白应用于角膜内皮细胞培养 Pending CN105814195A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013-244972 2013-11-27
JP2013244972 2013-11-27
PCT/JP2014/081917 WO2015080297A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Publications (1)

Publication Number Publication Date
CN105814195A true CN105814195A (zh) 2016-07-27

Family

ID=52432880

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480065134.XA Pending CN105814195A (zh) 2013-11-27 2014-11-26 层粘连蛋白应用于角膜内皮细胞培养

Country Status (10)

Country Link
US (1) US11624053B2 (enExample)
EP (1) EP3074508B1 (enExample)
JP (3) JP6470286B2 (enExample)
CN (1) CN105814195A (enExample)
BR (1) BR112016011096A2 (enExample)
CA (1) CA2931280A1 (enExample)
ES (1) ES2763433T3 (enExample)
MX (1) MX2016006915A (enExample)
RU (1) RU2704984C1 (enExample)
WO (1) WO2015080297A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法
CN113015429A (zh) * 2018-10-02 2021-06-22 学校法人同志社 用于保存角膜内皮细胞的方法和容器

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201903889T4 (tr) 2011-12-06 2019-04-22 Astellas Inst For Regenerative Medicine Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem.
WO2016067628A1 (ja) 2014-10-31 2016-05-06 京都府公立大学法人 ラミニンによる角膜の新規治療
US11918630B2 (en) 2014-10-31 2024-03-05 Kyoto Prefectural Public University Corporation Treatment of retina and nerve using laminin
JP6849957B2 (ja) * 2015-11-10 2021-03-31 国立大学法人京都大学 ラミニンフラグメント含有培地を用いる細胞培養方法
EP3375860A4 (en) * 2015-11-10 2019-07-03 Nikkiso Co., Ltd. CELL SUPPORT COMPOSITE AND METHOD FOR PRODUCING THE CELL SUPPORT COMPOSITE
AU2018215170B2 (en) * 2017-01-31 2021-11-11 Osaka University Differentiation control method for pluripotent stem cells
WO2019079809A1 (en) * 2017-10-22 2019-04-25 The Johns Hopkins University BIOMIMETIC PLATFORMS FOR MODELING VASCULAR PHYSIOPATHOLOGY, DIAGNOSIS AND THERAPY
WO2019102593A1 (ja) * 2017-11-24 2019-05-31 株式会社Ihi 細胞培養装置
JP6664755B1 (ja) * 2018-10-02 2020-03-13 学校法人同志社 角膜内皮細胞を保存するための方法および容器
WO2020184605A1 (ja) * 2019-03-12 2020-09-17 日産化学株式会社 角膜疾患治療剤
JP2023025311A (ja) * 2020-02-05 2023-02-22 味の素株式会社 タンパク質の製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1893988A (zh) * 2003-10-10 2007-01-10 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
CN102597217A (zh) * 2009-10-08 2012-07-18 国立大学法人大阪大学 人多能干细胞用培养基质及其用途
WO2013012087A1 (ja) * 2011-07-15 2013-01-24 国立大学法人大阪大学 角膜内皮細胞の調製方法

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Ｒｈｏ標的タンパク質Ｒｈｏキナーゼ
JP2000513220A (ja) 1996-06-05 2000-10-10 ザ ジェネラル ホスピタル コーポレイション ラミニン―５及び基底膜構造の形成
FR2765781B1 (fr) 1997-07-08 1999-09-24 Gioia Bruno Di Procede de fabrication d'un accessoire de mode, dispositif pour la mise en oeuvre du procede et accessoire de mode ainsi realise
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
AU4675300A (en) 1999-04-30 2000-11-17 Biostatum, Inc. Recombinant laminin 5
US6635616B2 (en) 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15
US6933273B2 (en) 2000-12-21 2005-08-23 Karl Tryggvason Isolated laminin 10
PE20021011A1 (es) 2001-03-23 2003-02-01 Bayer Corp Derivados quinazolinicos como inhibidores de la rho-quinasa
DE60218138T2 (de) 2001-03-23 2007-09-20 Bayer Pharmaceuticals Corp., West Haven Rho-kinase inhibitoren
US7109208B2 (en) 2001-04-11 2006-09-19 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
ES2305435T3 (es) 2002-01-10 2008-11-01 Bayer Healthcare Ag Inhibidores de la rho-quinasa.
JP4423043B2 (ja) 2002-01-23 2010-03-03 バイエル ファーマセチカル コーポレーション Ｒｈｏ−キナーゼ阻害剤
JP2004024852A (ja) 2002-04-30 2004-01-29 Amniotec:Kk 角膜内皮様シート、及びその作製方法
CA2483659A1 (en) * 2002-04-30 2003-11-13 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
EP1541559A4 (en) 2002-07-22 2007-08-22 Asahi Kasei Pharma Corp 5-SUBSTITUTED ISOQUINOLINE DERIVATIVE
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
EP1644365A2 (en) 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors
US20050182061A1 (en) 2003-10-02 2005-08-18 Jeremy Green Phthalimide compounds useful as protein kinase inhibitors
US20070004771A1 (en) 2003-10-06 2007-01-04 Glaxo Group Limited Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors
JP4764823B2 (ja) 2003-10-06 2011-09-07 グラクソ グループ リミテッド キナーゼ阻害剤としての１，６−二置換アザベンゾイミダゾールの調製
US20070123561A1 (en) 2003-10-06 2007-05-31 Dennis Lee Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors
US20070092550A1 (en) 2003-10-10 2007-04-26 Cellular Bioengineering, Inc. Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
DE602004030273D1 (de) 2003-10-10 2011-01-05 Ge Ming Lui Menschliche hornhautendothelzellen und verfahren zur gewinnung und kultivierung von zellen zur hornhautzelltransplantation
EP2468729B1 (en) 2003-10-15 2013-12-25 Ube Industries, Ltd. Novel indazole derivative
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
EP2438815A3 (en) 2004-01-23 2012-10-03 Advanced Cell Technology, Inc. Improved modalities for the treatment of degenerative diseases of the retina
CA2555792C (en) 2004-02-12 2013-04-02 Government Of The United States Of America, As Represented By Secretary, Department Of Health And Human Services Therapeutic administration of the scrambled anti-angiogenic peptide c16y
EP1720874A4 (en) 2004-02-24 2010-03-03 Bioaxone Therapeutique Inc 4-SUBSTITUTED PIPERIDINE DERIVATIVES
AR049333A1 (es) 2004-04-02 2006-07-19 Vertex Pharma Azaindoles inhibidores de proteinquinasas rock y otras proteinas quinasas. composiciones farmaceuticas.
JPWO2006057270A1 (ja) 2004-11-26 2008-06-05 旭化成ファーマ株式会社 含窒素３環化合物
KR101149954B1 (ko) 2005-08-30 2012-06-01 아사히 가세이 파마 가부시키가이샤 술폰아미드 화합물
US10052411B2 (en) 2006-01-19 2018-08-21 Senju Pharmaceutical Co., Ltd. Methods of treating corneal related diseases by corneal endothelial preparation which enables cells to grow in vivo
US20090175835A1 (en) 2006-02-07 2009-07-09 Korea Institute Of Radiological & Medical Sciences Composition for treating damage of central or peripheral nerve system
WO2007127172A2 (en) 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8951799B2 (en) 2007-01-04 2015-02-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent stem cells
WO2009028631A1 (ja) * 2007-08-29 2009-03-05 Senju Pharmaceutical Co., Ltd. 角膜内皮細胞接着促進剤
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
WO2010140464A1 (ja) 2009-06-05 2010-12-09 国立大学法人 熊本大学 細胞の分化誘導方法
RU2418067C1 (ru) 2009-12-03 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ культивирования клеток
WO2011080984A1 (en) 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
KR101966033B1 (ko) 2010-12-17 2019-04-04 바이오라미나 에이비 재조합 라미닌-521
JPWO2012173207A1 (ja) 2011-06-14 2015-02-23 独立行政法人理化学研究所 網膜細胞への分化誘導方法
JPWO2013047763A1 (ja) 2011-09-29 2015-03-30 オリエンタル酵母工業株式会社 ラミニン５１１を含んだ系で哺乳類細胞を培養する方法
JP6506023B2 (ja) 2011-11-14 2019-04-24 アステラス インスティテュート フォー リジェネレイティブ メディシン ヒトｒｐｅ細胞医薬品およびその使用
EP2784152B1 (en) 2011-11-25 2019-04-10 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
JP5985207B2 (ja) 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
TR201903889T4 (tr) * 2011-12-06 2019-04-22 Astellas Inst For Regenerative Medicine Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem.
US9351914B2 (en) 2012-03-25 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for modulating hair growth using truncated laminin-511
RS57257B1 (sr) 2012-12-03 2018-08-31 Biolamina Ab Metodi proizvodnje rpe ćelija
JP6518878B2 (ja) 2013-10-09 2019-05-29 株式会社ヘリオス 網膜色素上皮細胞の製造方法
US11918630B2 (en) 2014-10-31 2024-03-05 Kyoto Prefectural Public University Corporation Treatment of retina and nerve using laminin
WO2016067628A1 (ja) 2014-10-31 2016-05-06 京都府公立大学法人 ラミニンによる角膜の新規治療
CA3105205A1 (en) 2018-06-29 2020-01-02 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1893988A (zh) * 2003-10-10 2007-01-10 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
CN102597217A (zh) * 2009-10-08 2012-07-18 国立大学法人大阪大学 人多能干细胞用培养基质及其用途
WO2013012087A1 (ja) * 2011-07-15 2013-01-24 国立大学法人大阪大学 角膜内皮細胞の調製方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MONIQUE AUMAILLEY 等: "A simplified laminin nomenclature", 《MATRIX BIOLOGY》 *
李姝燕: "层粘连蛋白作用下角膜内皮细胞增殖与细胞骨架的相关性", 《眼科研究》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113015429A (zh) * 2018-10-02 2021-06-22 学校法人同志社 用于保存角膜内皮细胞的方法和容器
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法

Also Published As

Publication number Publication date
US20170002318A1 (en) 2017-01-05
US11624053B2 (en) 2023-04-11
JP2016539641A (ja) 2016-12-22
CA2931280A1 (en) 2015-06-04
RU2704984C1 (ru) 2019-11-01
EP3074508B1 (en) 2019-11-06
JP2019054828A (ja) 2019-04-11
WO2015080297A1 (en) 2015-06-04
MX2016006915A (es) 2017-01-23
ES2763433T3 (es) 2020-05-28
JP6470286B2 (ja) 2019-02-13
JP2020188778A (ja) 2020-11-26
RU2016125225A (ru) 2018-01-09
EP3074508A1 (en) 2016-10-05
BR112016011096A2 (pt) 2017-09-19

Similar Documents

Publication Publication Date Title
CN105814195A (zh) 层粘连蛋白应用于角膜内皮细胞培养
JP2024152767A (ja) ラミニンによる角膜の新規治療
Okumura et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue
JP7525939B2 (ja) Ｍｂｐ－ｆｇｆ組み換えタンパク質を用いた三次元線維芽細胞集合体の調製、及び当該線維芽細胞集合体を含むインビトロ３ｄ皮膚真皮モデル
Utheim et al. Concise review: altered versus unaltered amniotic membrane as a substrate for limbal epithelial cells
CN103403148A (zh) 通过细胞产生牙本质、牙骨质和牙釉质
US11918630B2 (en) Treatment of retina and nerve using laminin
JP2018500993A (ja) 改変内皮細胞を含む生体適合性インプラント
WO2015015655A1 (ja) フックス角膜内皮ジストロフィ不死化細胞株およびその作製法
Hazra et al. In vitro profiling of the extracellular matrix and integrins expressed by human corneal endothelial cells cultured on silk fibroin-based matrices
JPWO2015199041A1 (ja) 新規合成ペプチドおよびその利用
JP5812420B2 (ja) 細胞接着および遊走を促進するペプチド
Chan The Role of Adseverin in Regulating the Articular Chondrocyte Phenotype and Cartilage Homeostasis
Alrashidi The Study of Receptor of Egg Jelly Domain of Polycystic Kidney Disease-1 Gene Product and Its Interaction with Extracellular Matrix Protein
JP6792852B2 (ja) 角化歯肉誘導剤
KR102236977B1 (ko) 3차원 섬유아세포집합체 및 그의 생산방법
Duim et al. The mechanoresponse of hEPDC

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160727